CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial / C. Margini, L. Brodosi, S. Lorenzini, L. Catani, V. Giudice, R. Giordano, A. Casadei, D. Sollazzo, F.G. Foschi, M. Baccarani, M. Bernardi, R. Lemoli, P. Andreone. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - STAMPA. - (2014), pp. S242-S243. (Intervento presentato al convegno 49th Annual International Liver Congress of the European Association for the Study of the Liver tenutosi a London, England. nel April 9-13, 2014) [10.1016/S0168-8278(14)60681-4].
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial
L. BrodosiSecondo
Writing – Original Draft Preparation
;S. LorenziniWriting – Review & Editing
;L. CataniWriting – Review & Editing
;D. SollazzoData Curation
;M. BaccaraniSupervision
;M. BernardiSupervision
;R. LemoliPenultimo
Supervision
;P. AndreoneUltimo
Writing – Review & Editing
2014
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.